Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
detroit blog main
detroit top stories
gene therapy
3
×
indiana blog main
indiana top stories
life sciences
medicare
merck
3
×
national
national blog main
national top stories
new york blog main
3
×
new york top stories
pembrolizumab
3
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
alzheimer's disease
biogen
cancer
clinical trials
deals
diagnostics
drug prices
What
bio
roundup
companies
drug
acquisitions
albert
approval
arena’s
biggest
biogen’s
biopharmaceutical
bounty
bourla
ceo
cig
comeback
company
convo
corner
crispr
deals
delivered
earlier
expressing
failures
future
imports
ipo
life
littered
little
maker
maps
measured
moderna’s
nash
new
news
number
patients
Language
unknown
Current search:
merck
×
pembrolizumab
×
" new york blog main "
×
" gene therapy "
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More